Mucosal immune response to Tropheryma whipplei

International Journal of Medical Microbiology

Volumn 293, Issue 1, 2003, Pages 69-76

  Ring, Sabine ^a   Schneider, Thomas ^b   Martha, Thomas ^a  

^a DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

IFN ; IL 12; Predisposed immunodefects; Tropheryma whipplei; Whipple's disease

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; STAT1 PROTEIN; STAT2 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL MASS; ABDOMINAL PAIN; ARTHROPATHY; BACTERIAL GENETICS; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CYTOKINE PRODUCTION; DIARRHEA; FEVER; GENETIC DISORDER; GRAM POSITIVE BACTERIUM; HEART MURMUR; HEPATOMEGALY; HUMAN; HYPERPIGMENTATION; HYPOTENSION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INTESTINE BIOPSY; INTESTINE LIPODYSTROPHY; LYMPHADENOPATHY; MOLECULAR PHYLOGENY; MUCOSAL IMMUNITY; NONHUMAN; OCCULT BLOOD; PERIPHERAL EDEMA; REVIEW; SERODIAGNOSIS; SIGNAL TRANSDUCTION; SPLENOMEGALY; TH1 CELL; TROPHERYMA WHIPPLEI; WEIGHT REDUCTION;

EID: 0038297671     PISSN: 14384221     EISSN: None     Source Type: Journal    
DOI: 10.1078/1438-4221-00245     Document Type: Review

References (46)

1. Bach, E. A., Aguet, M., Schreiber, R. D.: The IFNγ receptor: a paradigma for cytokine receptor signaling. Annu. Rev. Immunol. 15, 563-591 (1997).
2. Bentley, S. D., Maiwald, M., Murphy, L. D., Pallen, M. J., Yeats, C. A., Dover, L. G., Norbertczak, H. T., Besra, G. S., Quail, M. A., Harris, D. E., von Herbay, A., Goble, A., Rutter, S., Squares, R., Squares, S., Barrell, B. G., Parkhill, J., Relman, D. A.: Sequencing and analysis of the genome of the Whipple's disease bacterium Tropheryma whipplei. Lancet 36, 637-644 (2003).
3. Bjerknes, R., Odegaard, S., Bjerkvig, R., Borkje, B., Laerum, O. D.: Whipple's disease: Demonstration of a persisting monocyte and macrophage dysfunction. Scand. J. Gastroenterol. 23, 611-619 (1988).
4. Black-Schaffer, B.: The tinctoral demonstration of a glycoprotein in Whipple's disease. Proc. Soc. Exp. Biol. Med. 72, 225-227 (1949).
5. Dobbins, W. O. III, Kawanishi, H.: Bacillary characteristics in Whipple's disease: an electron microscopic study. Gastroenterology 80, 1468-1475 (1981).
6. Dobbins, W. O. III: Is there a immune deficit in Whipple's disease? Dig. Dis. Sci. 26, 247-252 (1981).
7. Dobbins, W. O. III: The diagnosis of Whipple's disease [editorial]. N. Engl. J. Med. 332, 390-392 (1995).
8. Dobbins, W. O. III: Whipple's disease. Charles C. Thomas, Springfield, Illinois 1987.
9. Eck, M., Kreipe, H., Harmsen, D., Müller-Hermelink, H. K.: Invasion and destruction of mucosal plasma cells by Tropheryma whippelii. Hum. Pathol. 28, 1424-1428 (1997).
10. Fenollar, F., Raoult, D.: Whipple's disease. Clin. Diagn. Lab. Immunol. 8, 1-8 (2001).
11. Feurle, G. E., Dörken, B., Schöpf, E., Lenhard, V.: HLAB27 and defects in the T-cell system in Whipple's disease. Eur. J. Clin. Invest. 9, 385-389 (1979b).
12. Feurle, G. E., Marth, T.: An evaluation of antimicrobial treatment for Whipple's disease - Tetracycline versus trimethoprim-sulfamethoxazole. Dig. Dis. Sci. 39, 1642-1648 (1994).
13. Feurle, G. E., Volk, B., Waldherr, R.: Cerebral Whipple's disease with negative jejunal histology. N. Engl. J. Med. 300, 907-908 (1979a).
14. Fleming, J. L., Wiesner, R. H., Shorter, R. G.: Whipple's disease: Clinical, biochemical and histopathological features and assessment of treatment in 29 patients. Mayo Clin. Proc. 63, 539-551 (1988).
15. Fredricks, D. N., Relman, D. A.: Localization of Tropheryma whippelii rRNA in tissues from patients with whipple's disease. J. Infect. Dis. 183, 1229-1237 (2001).
16. Groll, A., Valberg, L. S., Simon, J. B., Eidinger, D., Wilson, D., Forsdyke, D. R.: Immunological defect in Whipple's disease. Gastroenterology 63, 943-950 (1972).
17. Keinath, R. D., Merrell, D. E., Vlietstra, R., Dobbins, W. O. III: Antibiotic treatment and relapse in Whipple's disease. Gastroenterology 88, 1867-1873 (1985).
18. Kent, T. H., Layton, J. M., Clifton, J. A., Schedl, H. P.: Whipple's disease: light and electron microscopic studies combined with clinical studies suggesting an infective nature. Lab. Invest. 12, 1163-1178 (1963).
19. Keren, D. F.: Whipple's disease: a review emphasizing immunology and microbiology. Crit. Rev. Clin. Lab. Sci. 14, 75-108 (1981).
20. La Scola, B., Fenollar, F., Fournier, P. E., Altwegg, M., Mallet, M. N., Raoult D.:. Description of Tropheryma whipplei gen. nov., sp. nov., the Whipple's disease bacillus. Int. J. Syst. Evol. Microbiol. 51, 1471-1479 (2001).
21. Liang, Z., La Scola, B., Raoult, D.: Monoclonal antibodies to immunodominant epitope of Tropheryma whipplei. Clin. Diagn. Lab. Immunol. 9, 156-159 (2002).
22. Maiwald, M., Ditton, H. J., von Herbay, A., Rainey, F. A., Stackebrandt, E.: Reassessment of the phylogenetic position of the bacterium associated with Whipple's disease and determination of the 16S-23S ribosomal intergenic spacer sequence. Int. J. Syst. Bacteriol. 46, 1078-1082 (1996).
23. Maiwald, M., Schuhmacher, F., Ditton, H. J., von Herbay, A.: Environmental occurrence of the Whipple's disease bacterium (Tropheryma whippelii). Appl. Environ. Microbiol. 64, 760-762 (1998).
24. Maizel, H., Ruffin, J. M., Dobbins, W. O. III.: Whipple's disease: a review of 19 patients from one hospital and a review of the literature since 1950. Medicine 49, 175-205 (1970).
25. Marth, T., Kleen, N., Stallmach, A., Ring, S., Aziz, S., Schmidt, C., Strober, W., Zeitz, M., Schneider, T.: Dysregulated peripheral and mucosal Th1/Th2 response in Whipple's disease. Gastroenterology 123, 1468-1477 (2002).
26. Marth, T., Neurath, M., Cuccherini, B. A., Strober, W.: Defects of monocyte interleukin-12 production and humoral immunity in Whipple's disease. Gastroenterology 113, 442-448 (1997).
27. Marth, T., Raoult, D.: Whipple's disease. Lancet 361, 239-246 (2003).
28. Marth, T., Roux, M., von Herbay, A., Meuer, S. C., Feurle, G. E.: Persistent reduction of complement receptor 3 alpha-chain expressing mononuclear blood cells and transient inhibitory serum factors in Whipple's disease. Clin. Immunol. Immunopathol. 72, 217-226 (1994).
29. Martin, F. F., Vilseck, J., Dobbins, W. O. III, Buckley, C. E. III, Tyor, M. P.: Immunological alterations in patients with treated Whipple's disease. Gastroenterology 63, 6-18 (1972).
30. Maxwell, J. D., Ferguson, A., McKay, A. M., Imrie, R. C., Watson, W. C.: Lymphocytes in Whipple's disease. Lancet 1(7548), 887-889 (1968).
31. Raoult, D., Birg, M. L., La Scola, B., Fournier, P. E., Enea, M., Lepidi, H., Roux, V., Piette, J. C., Vandenesch, F., Vital-Durand, D., Marrie, T. J.: Cultivation of the bacillus of Whipple's disease. N. Engl. J. Med. 342, 620-625 (2000).
32. Raoult, D., La Scola, B., Lecocq, P., Lepidi, H., Fournier, P. E.: Culture and immunological detection of Tropheryma whippelii in the duodenum of a patient with Whipple's disease. JAMA 285, 1039-1043 (2001).
33. Relman, D. A., Schmidt, T. M., MacDermott, R. P., Falkow, S.: Identification of the uncultured bacillus of Whipple's disease. N. Engl. J. Med. 327, 293-301 (1992).
34. Schlup, M., Scheurer, U., Bosseckert, H., Clemencon, G., Deyle, P., Rösch, W.: Der Morbus Whipple - eine kooperative Studie. Schweiz. Rundschau. Med. (Praxis) 70, 1460-1466 (1981).
35. Schneider, T., Stallmach, A., von Herbay, A., Marth, T., Strober, W., Zeitz, M.: Treatment of refractory Whipple's disease with recombinant interferon-gamma. Ann. Intern. Med. 129, 875-877 (1998).
36. Schoedon, G., Goldenberger, D., Forrer, R., Gunz, A., Dutly, F., Höchli, M., Altwegg, M., Schaffner, A.: Deactivation of macrophages with interleukin-4 is the key to the isolation of Tropheryma whippelii. J. Infect. Dis. 176, 672-677 (1997).
37. Silva, M. T., Macedo, P. M., Nunes, J. F. M.: Ultrastructure of bacilli and bacillary origin of the macrophagic inclusions in Whipple's disease. J. Gen. Microbiol. 131, 1001-1013 (1985).
38. Street, S., Donoghue, H. D., Neild, G. H.: Tropheryma whippelii DNA in saliva of healthy people. Lancet 354, 1178-1179 (1999).
39. Trier, J. S., Phelps, P. C., Eidelmann, S., Rubin, C. E.: Whipple's disease: light and electron microscope correlation of jejunal mucosal histology with antibiotic treatment and clinical status. Gastroenterology 48, 684-707 (1965).
40. Trinchieri, G.: Function and clinical use of interleukin-12. Curr. Opin. Hematol. 4, 59-66 (1997).
41. Vital-Durand, D., Lecomte, C., Cathebras, P., Rousset, H., Godeau, P.: Whipple disease: clinical review of 52 cases. Medicine 76, 170-184 (1997).
42. von Herbay, A., Ditton, H. J., Schuhmacher, F., Maiwald, M.: Whipple's disease: Staging and monitoring by cytology and polymerase chain reaction of cerebrospinal fluid. Gastroenterology 113, 434-441 (1997).
43. von Herbay, A., Windler, F., Heckmayr, M., Langkowski, J., Kraas, E., Otto, H. F.: Abdomineller Pseudotumor als klinische Manifestation eines Morbus Whipple - T-cell index as an indicator of disease activity and a parameter of the duration of therapy. Dtsch. Med. Wschr. 112, 1621-1625 (1987).
44. Whipple, G. H.: A hitherto undescribed disease characterized anatomically by deposits of fat and fatty acids in the intestinal and mesenteric lymphatic tissues. Bull. Johns Hopkins Hosp. 18, 382-391 (1907).
45. Wilson, K. H., Blitchington, R., Frothingham, R., Wilson, J. A. P.: Phylogeny of the Whipple's disease-associated bacterium. Lancet 338, 474-475 (1991).
46. Yardley, J. H., Hendrix, T. R.: Combined electron and light microscopy in Whipple's disease: demonstration of "bacillary bodies" in the intestine. Bull. Johns Hopkins Hosp. 109, 80-98 (1961).